Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Urinary Bladder Neoplasms 41Non-Muscle Invasive Bladder Neoplasms 25Carcinoma, Transitional Cell 17Neoplasms 6Urologic Neoplasms 4Urologic Diseases 3Urogenital Neoplasms 3Urinary Bladder Diseases 3Neoplasms by Site 3Carcinoma in Situ 3Carcinoma 3Recurrence 2Virus Diseases 1Urothelial Carcinoma of the Bladder 1Urothelial Carcinoma Ureter 1Urogenital Diseases 1Urethral Neoplasms 1Ureteral Neoplasms 1Neoplasms by Histologic Type 1Neoplasm Recurrence, Local 1Mycobacterium Infections 1Male Urogenital Diseases 1Female Urogenital Diseases 1Disease 1Adenoviridae Infections 1

Interventions

Gemcitabine 24Cisplatin 18Carboplatin 10Paclitaxel 9Specimen Handling 6Nivolumab 6Doxorubicin 6Docetaxel 6pembrolizumab 5Magnetic Resonance Spectroscopy 5cabozantinib 4avelumab 4Vinblastine 4Radiotherapy 4Methotrexate 4Fluorouracil 4enfortumab vedotin 3atezolizumab 3aflibercept 3Trastuzumab 3Sunitinib 3Ramucirumab 3Platinum 3Ipilimumab 3CTLA-4 Antigen 3Biopsy 31,2-diaminocyclohexaneplatinum II citrate 3vinflunine 2pegfilgrastim 2Sorafenib 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Urethral Neoplasms × Mitomycin × Genitourinary × Clear all
NCT03617913 2023-01-06

Avelumab in Combination With Fluorouracil and Mitomycin or Cisplatin and Radiation Therapy in Treating Participants With Muscle-Invasive Bladder Cancer

Mayo Clinic

Phase 2 Completed
2 enrolled 8 charts
Genitourinary

Urinary Bladder Neoplasms, Ureteral Neoplasms, Urethral Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡